Parenteral expansion Leverage the recent Plas-Tech acquisition and Equinox syringe portfolio to target customers needing prefillable syringes and small-batch parenteral manufacturing, expanding into biologics and high-viscosity formulations.

End-to-end support Position as a one-stop partner from concept to scale for drug-device programs, highlighting capabilities across prototyping, piloting, tooling, and global manufacturing to win programs seeking streamlined development-to-market timelines.

Global footprint Emphasize multi-site manufacturing presence in Europe and the US with sales representation in China, India, and Uruguay to pursue region-specific device components and localized supply chains for international pharma customers.

Inhalation and device focus Capitalize on participation in inhalation and aerosol forums and events to generate opportunities in inhalation devices and related nozzle or componentry, aligning with pharma companies advancing inhaled therapies.

Strategic partnerships Promote collaborations with specialists in micro-moulding and manufacturing efficiency (for example Cronomol and DATA Business Solutions Group) as a value-add for customers seeking modular, cost-effective production solutions.